QDIS Blog

I came across this article and think there may be a point to it. The authors claim that outsourcing in the pharmaceutical industry is no longer an option but a necessity.

BMS claims outsourcing no longer an option

While there is some truth to this, it also ignores what would happen if there is a down-turn in the industry or if a major problem should happen at a contract manufacturer. Although I hope it doesn’t happen, if such an event would occur, it would definitely have a major impact on the industry. Also, I think if major pharma companies have an excess of capacity, they won’t outsource but keep it in-house.

I firmly believe that outsourcing is indeed important but I don’t share the opinion that it is no longer optional. The choice to outsource should be made carefully and with a eye on what is important. not all activities can or should be outsourced. Outsourcing of activities that bring an added value to the company are ones that are prime candidates for outsourcing.

Technorati Tags: Bristol-Myers Squibb, drug development, outsourcing

Email Ed Vawter

Bookmark it with: | del.icio.us | Digg it | Furl | Simpy | Spurl | My Yahoo! |

I’ve posted several times that I think Roche is doing a great job getting the capacity to provide Tamiflu to the world. Roche today announced that they now have in place a supply chain for the US.

U.S.-BASED SUPPLY CHAIN FOR TAMIFLU FULLY OPERATIONAL

They don’t specify who is providing the bulk active, but I have my suspicions. It is again good to note that if something should occur and Tamiflu is needed on a vast scale, Roche already has a supply chain in place.

Technorati Tags: Roche, Tamiflu

Email Ed Vawter

Bookmark it with: | del.icio.us | Digg it | Furl | Simpy | Spurl | My Yahoo! |